Artisan Mid Cap remains mired in a multiyear performance rut, but a thoughtful investment process and experienced leadership are reasons to remain optimistic. The team is sticking to its core investment philosophy, but the managers made changes to the analyst team, showing that they're not just hoping things will turn around.
Artisan Mid Cap Fund Investor Class ARTMX
- NAV / 1-Day Return 35.33 / +0.94 %
- Total Assets 2.9B
-
Adj. Expense Ratio
1.210%
- Expense Ratio 1.200%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 63%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 10:22 PM GMT+0
Morningstar’s Analysis ARTMX
Will ARTMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
argenx SE ADR | 4.94 | 157M | Healthcare |
Ascendis Pharma AS | 4.52 | 144M | Healthcare |
Comfort Systems USA Inc | 3.90 | 124M | Industrials |
West Pharmaceutical Services Inc | 3.78 | 121M | Healthcare |
Lattice Semiconductor Corp | 3.38 | 108M | Technology |
RBC Bearings Inc | 3.03 | 97M | Industrials |
Woodward Inc | 2.82 | 90M | Industrials |
Twist Bioscience Corp | 2.78 | 89M | Healthcare |
BlackRock Liquidity T-Fund Instl | 2.72 | 87M | Cash and Equivalents |
Spotify Technology SA | 2.58 | 82M | Communication Services |